GSTM1 and COVID-19: The meta‐analysis, included 1210 COVID‐19 patients that among them 224 were with severe disease (18.5%), suggested that in severe COVID‐19 patients compared to milder forms of the disease, Hb levels essentially decreased that needs clinical studies to investigate the effectiveness of blood transfusion support in prevention of progress to severe disease and death.2